 In 1987, he helped Prusoff’s laboratory discover that d4T, a nucleoside analog, had selective activity against HIV.Schinazi is best known for his involvement in the discovery and/or development of innovative anti-HIV, HBV, and HCV drugs on the market.To date, he has been involved in the development of five FDA-approved drugs of which three are used in eight different drug combinations.